Attenuation of morphine tolerance by intrathecal gabapentin is associated with suppression of morphine-evoked excitatory amino acid release in the rat spinal cord

Jui A. Lin, Meei Shyuan Lee, Ching Tang Wu, Chun Chang Yeh, Shinn Long Lin, Zhi Hong Wen, Chih Shung Wong

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

This study was designed to investigate the effect of acute and chronic intrathecal (i.t.) injection of gabapentin (GBP) on the antinociceptive effect of morphine and tolerance development using a tail-flick latency test. Levels of excitatory amino acids (EAA) in i.t. CSF dialysates were also measured by high performance liquid chromatography. Male Wistar rats were implanted with either one or two i.t. catheters for drug injection or pump infusion and with a microdialysis probe for CSF dialysate collection. The effect of acute GBP (10 μg i.t.) injection on the morphine dose response was examined in both naïve rats and rats made tolerant by continuous infusion of morphine (15 μg/h i.t.) for 5 days. At such a low dose (10 μg i.t.), GBP did not enhance morphine's antinociception in naïve rats. In morphine-tolerant rats, however, acute GBP (10 μg i.t.) injection potentiated morphine's antinociception and yielded a 14.6-fold shift in morphine's dose-response curve. When GBP (10 μg/h i.t.) was co-infused with morphine (15 μg/h i.t.) to examine its effect on the development of morphine tolerance, GBP attenuated the development of morphine tolerance. The effect of GBP and morphine on CSF glutamate and aspartate levels was examined in naïve rats, and the effect of morphine challenge on CSF glutamate and aspartate levels was examined in rats previously infused for 5 days with morphine alone or morphine plus GBP. Acute injection of GBP (10 μg i.t.), morphine (50 μg i.t.), or GBP (10 μg i.t.) followed by morphine (50 μg i.t.) 30 min later had no significant effect on CSF EAA concentration in naïve rats; however, in tolerant rats, morphine challenge (50 μg i.t.) increased aspartate and glutamate levels to 221 ± 22% and 296 ± 43%, respectively, of those before morphine challenge, and this phenomenon was inhibited by GBP co-infusion. Our results show that GBP, at a dose without enhanced effect on morphine's antinociception in naïve rats, not only potentiates morphine's antinociceptive effect in morphine-tolerant rats but also attenuates the development of morphine tolerance. The mechanism of the effect of GBP on morphine tolerance might be via suppression of the EAA concentration in spinal CSF dialysate.

Original languageEnglish
Pages (from-to)167-173
Number of pages7
JournalBrain Research
Volume1054
Issue number2
DOIs
Publication statusPublished - Aug 30 2005
Externally publishedYes

Fingerprint

Excitatory Amino Acids
Morphine
Spinal Cord
Spinal Injections
Dialysis Solutions
gabapentin
Aspartic Acid
Glutamic Acid

Keywords

  • Drug tolerance
  • Excitatory amino acid
  • Gabapentin
  • Morphine

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Attenuation of morphine tolerance by intrathecal gabapentin is associated with suppression of morphine-evoked excitatory amino acid release in the rat spinal cord. / Lin, Jui A.; Lee, Meei Shyuan; Wu, Ching Tang; Yeh, Chun Chang; Lin, Shinn Long; Wen, Zhi Hong; Wong, Chih Shung.

In: Brain Research, Vol. 1054, No. 2, 30.08.2005, p. 167-173.

Research output: Contribution to journalArticle

Lin, Jui A. ; Lee, Meei Shyuan ; Wu, Ching Tang ; Yeh, Chun Chang ; Lin, Shinn Long ; Wen, Zhi Hong ; Wong, Chih Shung. / Attenuation of morphine tolerance by intrathecal gabapentin is associated with suppression of morphine-evoked excitatory amino acid release in the rat spinal cord. In: Brain Research. 2005 ; Vol. 1054, No. 2. pp. 167-173.
@article{fb68aa4dc0df4be2b78b8c8571363f8a,
title = "Attenuation of morphine tolerance by intrathecal gabapentin is associated with suppression of morphine-evoked excitatory amino acid release in the rat spinal cord",
abstract = "This study was designed to investigate the effect of acute and chronic intrathecal (i.t.) injection of gabapentin (GBP) on the antinociceptive effect of morphine and tolerance development using a tail-flick latency test. Levels of excitatory amino acids (EAA) in i.t. CSF dialysates were also measured by high performance liquid chromatography. Male Wistar rats were implanted with either one or two i.t. catheters for drug injection or pump infusion and with a microdialysis probe for CSF dialysate collection. The effect of acute GBP (10 μg i.t.) injection on the morphine dose response was examined in both na{\"i}ve rats and rats made tolerant by continuous infusion of morphine (15 μg/h i.t.) for 5 days. At such a low dose (10 μg i.t.), GBP did not enhance morphine's antinociception in na{\"i}ve rats. In morphine-tolerant rats, however, acute GBP (10 μg i.t.) injection potentiated morphine's antinociception and yielded a 14.6-fold shift in morphine's dose-response curve. When GBP (10 μg/h i.t.) was co-infused with morphine (15 μg/h i.t.) to examine its effect on the development of morphine tolerance, GBP attenuated the development of morphine tolerance. The effect of GBP and morphine on CSF glutamate and aspartate levels was examined in na{\"i}ve rats, and the effect of morphine challenge on CSF glutamate and aspartate levels was examined in rats previously infused for 5 days with morphine alone or morphine plus GBP. Acute injection of GBP (10 μg i.t.), morphine (50 μg i.t.), or GBP (10 μg i.t.) followed by morphine (50 μg i.t.) 30 min later had no significant effect on CSF EAA concentration in na{\"i}ve rats; however, in tolerant rats, morphine challenge (50 μg i.t.) increased aspartate and glutamate levels to 221 ± 22{\%} and 296 ± 43{\%}, respectively, of those before morphine challenge, and this phenomenon was inhibited by GBP co-infusion. Our results show that GBP, at a dose without enhanced effect on morphine's antinociception in na{\"i}ve rats, not only potentiates morphine's antinociceptive effect in morphine-tolerant rats but also attenuates the development of morphine tolerance. The mechanism of the effect of GBP on morphine tolerance might be via suppression of the EAA concentration in spinal CSF dialysate.",
keywords = "Drug tolerance, Excitatory amino acid, Gabapentin, Morphine",
author = "Lin, {Jui A.} and Lee, {Meei Shyuan} and Wu, {Ching Tang} and Yeh, {Chun Chang} and Lin, {Shinn Long} and Wen, {Zhi Hong} and Wong, {Chih Shung}",
year = "2005",
month = "8",
day = "30",
doi = "10.1016/j.brainres.2005.06.058",
language = "English",
volume = "1054",
pages = "167--173",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Attenuation of morphine tolerance by intrathecal gabapentin is associated with suppression of morphine-evoked excitatory amino acid release in the rat spinal cord

AU - Lin, Jui A.

AU - Lee, Meei Shyuan

AU - Wu, Ching Tang

AU - Yeh, Chun Chang

AU - Lin, Shinn Long

AU - Wen, Zhi Hong

AU - Wong, Chih Shung

PY - 2005/8/30

Y1 - 2005/8/30

N2 - This study was designed to investigate the effect of acute and chronic intrathecal (i.t.) injection of gabapentin (GBP) on the antinociceptive effect of morphine and tolerance development using a tail-flick latency test. Levels of excitatory amino acids (EAA) in i.t. CSF dialysates were also measured by high performance liquid chromatography. Male Wistar rats were implanted with either one or two i.t. catheters for drug injection or pump infusion and with a microdialysis probe for CSF dialysate collection. The effect of acute GBP (10 μg i.t.) injection on the morphine dose response was examined in both naïve rats and rats made tolerant by continuous infusion of morphine (15 μg/h i.t.) for 5 days. At such a low dose (10 μg i.t.), GBP did not enhance morphine's antinociception in naïve rats. In morphine-tolerant rats, however, acute GBP (10 μg i.t.) injection potentiated morphine's antinociception and yielded a 14.6-fold shift in morphine's dose-response curve. When GBP (10 μg/h i.t.) was co-infused with morphine (15 μg/h i.t.) to examine its effect on the development of morphine tolerance, GBP attenuated the development of morphine tolerance. The effect of GBP and morphine on CSF glutamate and aspartate levels was examined in naïve rats, and the effect of morphine challenge on CSF glutamate and aspartate levels was examined in rats previously infused for 5 days with morphine alone or morphine plus GBP. Acute injection of GBP (10 μg i.t.), morphine (50 μg i.t.), or GBP (10 μg i.t.) followed by morphine (50 μg i.t.) 30 min later had no significant effect on CSF EAA concentration in naïve rats; however, in tolerant rats, morphine challenge (50 μg i.t.) increased aspartate and glutamate levels to 221 ± 22% and 296 ± 43%, respectively, of those before morphine challenge, and this phenomenon was inhibited by GBP co-infusion. Our results show that GBP, at a dose without enhanced effect on morphine's antinociception in naïve rats, not only potentiates morphine's antinociceptive effect in morphine-tolerant rats but also attenuates the development of morphine tolerance. The mechanism of the effect of GBP on morphine tolerance might be via suppression of the EAA concentration in spinal CSF dialysate.

AB - This study was designed to investigate the effect of acute and chronic intrathecal (i.t.) injection of gabapentin (GBP) on the antinociceptive effect of morphine and tolerance development using a tail-flick latency test. Levels of excitatory amino acids (EAA) in i.t. CSF dialysates were also measured by high performance liquid chromatography. Male Wistar rats were implanted with either one or two i.t. catheters for drug injection or pump infusion and with a microdialysis probe for CSF dialysate collection. The effect of acute GBP (10 μg i.t.) injection on the morphine dose response was examined in both naïve rats and rats made tolerant by continuous infusion of morphine (15 μg/h i.t.) for 5 days. At such a low dose (10 μg i.t.), GBP did not enhance morphine's antinociception in naïve rats. In morphine-tolerant rats, however, acute GBP (10 μg i.t.) injection potentiated morphine's antinociception and yielded a 14.6-fold shift in morphine's dose-response curve. When GBP (10 μg/h i.t.) was co-infused with morphine (15 μg/h i.t.) to examine its effect on the development of morphine tolerance, GBP attenuated the development of morphine tolerance. The effect of GBP and morphine on CSF glutamate and aspartate levels was examined in naïve rats, and the effect of morphine challenge on CSF glutamate and aspartate levels was examined in rats previously infused for 5 days with morphine alone or morphine plus GBP. Acute injection of GBP (10 μg i.t.), morphine (50 μg i.t.), or GBP (10 μg i.t.) followed by morphine (50 μg i.t.) 30 min later had no significant effect on CSF EAA concentration in naïve rats; however, in tolerant rats, morphine challenge (50 μg i.t.) increased aspartate and glutamate levels to 221 ± 22% and 296 ± 43%, respectively, of those before morphine challenge, and this phenomenon was inhibited by GBP co-infusion. Our results show that GBP, at a dose without enhanced effect on morphine's antinociception in naïve rats, not only potentiates morphine's antinociceptive effect in morphine-tolerant rats but also attenuates the development of morphine tolerance. The mechanism of the effect of GBP on morphine tolerance might be via suppression of the EAA concentration in spinal CSF dialysate.

KW - Drug tolerance

KW - Excitatory amino acid

KW - Gabapentin

KW - Morphine

UR - http://www.scopus.com/inward/record.url?scp=24044439144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24044439144&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2005.06.058

DO - 10.1016/j.brainres.2005.06.058

M3 - Article

C2 - 16054118

AN - SCOPUS:24044439144

VL - 1054

SP - 167

EP - 173

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -